Therapeutic potential of α-glucosidase inhibitors to prevent postprandial endothelial dysfunction.
Level 5 - mechanism / opinion, no new human data
Narrative review describing mechanisms and clinical concepts without systematic review methodology
PubMed 25109946 · doi:10.1536/ihj.14-194
What was done
This narrative review synthesized literature on the relationship between postprandial glucose spikes and endothelial dysfunction, and examined the proposed mechanisms and cardiovascular protective effects of alpha-glucosidase inhibitors (α-GIs).
What was found
The abstract reports no quantitative data or effect estimates. It summarizes that postprandial hyperglycemia induces endothelial dysfunction that contributes to atherosclerosis, and notes that α-GIs can mitigate these spikes while exerting incretin-like and other pleiotropic effects.
Why it matters
Highlights the targeting of postprandial glucose excursions via alpha-glucosidase inhibitors as a potential therapeutic approach to protect vascular endothelial function and reduce cardiovascular events.
Limits
As a narrative review, it lacks a systematic search protocol, quality appraisal of included studies, and quantitative data in the abstract. Causality between postprandial glycemic control by α-GIs and hard cardiovascular outcome reduction cannot be established from this summary.
Cited by
- supports Whenever blood sugar levels cross above 140 mg/dL, arterial lining damage and vessel wall inflammation begin to occur.